𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Consensus conference: Implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice – Report of a European workshop

✍ Scribed by Pier Luigi Zinzani; Francesco d’Amore; Emilio Bombardieri; Caroline Brammer; José Gómez Codina; Tim Illidge; Wojciech Jurczak; Werner Linkesch; Franck Morschhauser; Elisabeth Vandenberghe; Achiel Van Hoof


Book ID
116429538
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
197 KB
Volume
44
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Consensus conference on the use of 90-yt
✍ Umberto Vitolo; Giovanni Barosi; Stefano Fanti; Alessandro M. Gianni; Maurizio M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

90-yttrium-ibritumomab-tiuxetan is approved for treatment of rituximab-relapsed/refractory CD201 follicular B-cell lymphoma and as consolidation therapy in untreated follicular lymphoma. Recommendations on the use of 90-yttrium-ibritumomab tiuxetan were issued in a consensus conference, sponsored by